The global Antihemophilic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Antihemophilic Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antihemophilic Factor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antihemophilic Factor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antihemophilic Factor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Biogen Idec
Bayer
Octapharma
Novo Nordisk
Baxter
Genetics Institute
Wyeth Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Powder
Liquid

Segment by Application
Hospital
Clinic